ArticleTransfusion2025
Frequent apheresis donation is not associated with adverse bone health in donors aged 45 years and over-Results from a cohort study in Australia.
Article in Transfusion, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundWe investigated whether frequent apheresis donors have altered risk of bone fractures, and prescription of osteoporosis medicine//s due to their repeated exposure to citrate anticoagulant.
methodsWe used the Sax Institute's 45 and Up Study data linked with blood donation and other health-related datasets. We used a "5-year qualification period" method to identify active donors who donated at least one (any type) donation in the first and fifth year of the "qualification period." We categorized donors into 0, 1-29, and 30+ donation groups based on the number of apheresis donations made during the qualification period. We then compared the risk of bone fractures, and initiation of osteoporosis medicine/s in the years following the "qualification period" between the groups, using Cox proportional-hazards models including several potential confounders.
resultsA total of 7369 donors met the qualification criteria, of which 2033 (27.6%) made at least one apheresis donation. Of those donating by apheresis, 381 (18.7%) also made platelet as well as plasma donation, and rest donated plasma only. The median follow-up time for overall bone fractures was 5.49 years/per-donor (Q1-Q3, 5.27-5.95). In the fully adjusted models, compared to donors not making any apheresis donation, the hazard ratio for all-cause bone fractures, osteoporotic bone fractures, and initiation of osteoporosis medicine/s in donors donating 30+ apheresis donations was 0.96 (95% CI: 0.58-1.60), 0.73 (95% CI: 0.29-1.82), and 1.09 (95% CI: 0.66-1.81), respectively.
conclusionsWe did not observe a statistically significant change in risk of bone fractures, and initiation of osteoporosis medicine/s in frequent apheresis donors predominantly consisting of plasmapheresis donors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.